Target intelligence / Profile preview

Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 (SERCA2) (SERCA2)

Target
SERCA2
Molecular classification
Enzyme, Transporter
01

Overview

ATP2A2 encodes the sarcoplasmic/endoplasmic reticulum calcium ATPase 2 (SERCA2), a magnesium-dependent P-type ATPase that plays a critical role in maintaining intracellular calcium homeostasis. It catalyzes the translocation of calcium ions from the cytosol into the sarcoplasmic or endoplasmic reticulum lumen, coupled with ATP hydrolysis. This process is essential for muscle relaxation and contraction cycles in cardiac and skeletal muscles, as well as calcium-dependent signaling in non-muscle cells. Dysregulation or downregulation of SERCA2 is a hallmark of cardiovascular diseases, particularly heart failure and diabetic cardiomyopathy, where impaired calcium reuptake leads to diastolic and systolic dysfunction. Conversely, heterozygous loss-of-function mutations in ATP2A2 cause Darier disease, a rare skin disorder characterized by loss of keratinocyte adhesion and abnormal keratinization. In therapeutics, SERCA2a is targeted for activation by small molecules like istaroxime and gene therapies (e.g., AAV1.SERCA2) to restore cardiac function, while its inhibition by compounds like thapsigargin is explored in oncology to induce endoplasmic reticulum stress and apoptosis in cancer cells.

Other names
ATP2BDARDDSarcoplasmic reticulum Ca(2+)-ATPase 2Calcium pump 2ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2Endoplasmic reticulum class 1/2 Ca(2+) ATPase
02

Mechanism of action

Activation of SERCA2a to enhance sarcoplasmic reticulum calcium reuptake (improving cardiac relaxation and contractility in heart failure), or inhibition of SERCA2 to disrupt intracellular calcium homeostasis, triggering endoplasmic reticulum stress and apoptosis (used as an anti-tumor strategy).

03

Biological functions

Calcium ion transmembrane transportEndoplasmic reticulum calcium ion homeostasisRegulation of cardiac muscle contractionAutophagyCell adhesionOther
04

Disease associations

Cardiovascular diseaseCancerNeurodegenerative diseaseOther
05

Safety considerations

Arrhythmia risk due to calcium overloadEndoplasmic reticulum stressImpaired epidermal cell adhesion (Darier-like skin lesions)Increased susceptibility to infectionsApoptosis in healthy cells from non-selective inhibition
06

Interacting drugs

5 more in the full profile.

07

Biomarkers

SERCA2 protein expression levelATP2A2 mRNA expression levelIntracellular calcium levelsSarcoplasmic reticulum calcium reuptake rate

Beyond the preview

Go deeper on Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 (SERCA2) (SERCA2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 (SERCA2) (SERCA2).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call